A detailed history of Gamma Investing LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Gamma Investing LLC holds 664 shares of IONS stock, worth $24,123. This represents 0.0% of its overall portfolio holdings.

Number of Shares
664
Previous 361 83.93%
Holding current value
$24,123
Previous $17.2 Million 54.61%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$40.06 - $51.86 $12,138 - $15,713
303 Added 83.93%
664 $26.6 Million
Q2 2024

Jul 02, 2024

SELL
$36.45 - $47.7 $9,148 - $11,972
-251 Reduced 41.01%
361 $17.2 Million
Q1 2024

Apr 05, 2024

BUY
$42.03 - $53.55 $4,707 - $5,997
112 Added 22.4%
612 $26.5 Million
Q4 2023

Feb 01, 2024

BUY
$43.39 - $51.63 $21,695 - $25,815
500 New
500 $25.7 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.16B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.